The deadly cancers left behind by 50 years of success

The article discusses the progress and challenges in cancer treatment over the past 50 years. While overall cancer survival rates have improved, with half of people with cancer now surviving, the lack of progress for certain forms of the disease remains a concern. The article highlights that certain types of cancer, such as pancreatic, lung, and brain cancer, continue to have very low survival rates. This disparity in progress is worrying experts, who emphasize the need for more research and investment to address these deadlier forms of cancer. The article suggests that while the advancements in cancer treatment, such as targeted therapies and immunotherapies, have been significant, the lack of breakthroughs for some cancers underscores the ongoing challenges in the field. Experts call for a renewed focus and commitment to address these unmet needs and ensure that the progress made in cancer care benefits all patients, regardless of the type of cancer they are facing.